Barclays raised the firm’s price target on Allegion (ALLE) to $156 from $135 and keeps an Underweight rating on the shares following the earnings report. The firm says the company’s Americas non-residential sales outlook is stronger than it expected.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLE:
